secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2023-08-14T23:59:59+00:00
Accession:  0001510964-23-000030
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences Q2 revenue $4.0M; gross margin 43.3%, operating loss narrows to $1.1M
--------------------------------------------------------------------------------

- Revenue of $4.0M, down 4% YoY from $4.1M; units sold down 16%, offset by higher average selling price.
- Gross margin improved to 43.3% vs 30.7% YoY; operating loss narrowed to $1.1M from $2.3M.
- Cash balance $1.7M at quarter-end vs $0.6M at FY2022; generated $2.4M cash from operations in H1 2023 (incl. $2.5M ERC).
- Extinguished outstanding note payable; evaluating strategic options including merger or sale.
- Maintained #1 hemp extract brand in natural product retail channel; launched PlusCBD Reserve Collection Extra Gummies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000151096423000030/0001510964-23-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000151096423000030/cvsi-20230814.htm
  HTML page:      https://secwatch.observer/filing/0001510964-23-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer